Human erythropoietin increases the pro-angiogenic potential of A2780 ovarian adenocarcinoma cells under hypoxic conditions
- 26 June 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 30 (3) , 1455-1462
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Absence of functional EpoR expression in human tumor cell linesBlood, 2010
- Evaluating Erythropoietin-Associated Tumor Progression Using Archival Tissues from a Phase III Clinical TrialStem Cells, 2009
- RNA Interference-Mediated Inhibition of Erythropoietin Receptor Expression Suppresses Tumor Growth and Invasiveness in A2780 Human Ovarian Carcinoma CellsThe American Journal of Pathology, 2009
- Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cellsInternational Journal of Cancer, 2007
- Erythropoietin2004
- Brain Capillary Endothelial Cells Express two forms of Erythropoietin Receptor mRNAEuropean Journal of Biochemistry, 1996
- Recombinant human erythropoietin stimulates angiogenesis in vitroKidney International, 1995
- Erythropoietin receptor mRNA expression in human endothelial cells.Proceedings of the National Academy of Sciences, 1994
- Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cellsKidney International, 1993
- Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.Proceedings of the National Academy of Sciences, 1990